Results 131 to 140 of about 3,050 (168)

A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens. [PDF]

J Virol
Fan W, Zeng X, Chen Y, Yu Q, Zhang Z, Tian G, Liu C, Bao H, Qi X, Wu L, Zhang Y, Liu Y, Wang S, Cui H, Duan Y, Chen H, Gao Y.   +16 more
europepmc   +1 more source

Marek's Disease Virus (MDV) Meq Oncoprotein Plays Distinct Roles in Tumor Incidence, Distribution, and Size. [PDF]

Viruses
Ajithdoss DK, Liao Y, Reddy SM, Lupiani B.   +3 more
europepmc   +1 more source

Comparative transcriptomic analysis of chicken immune organs affected by Marek's disease virus infection at latency phases. [PDF]

Front Physiol
Ding Y, Dunn J, Zhang H, Zhao K, Song J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Marek's Disease Virus

1985
Publisher Summary Marek's disease (MD)—a malignant lymphomatosis in chickens—is caused by Marek's disease virus (MDV) of the family Herpesviridae. This chapter reviews recent advances in MD research, especially in the field of molecular biology. Various antigens present in MDV virions, MDV-infected cells, or MD lymphoma cells have been suspected as ...
S, Kato, K, Hirai
openaire   +2 more sources

Marek's Disease: A Review

World's Poultry Science Journal, 1969
(1969). Marek's Disease: A Review. World's Poultry Science Journal: Vol. 25, No. 1, pp. 35-45.
openaire   +2 more sources

A study of vaccination against Marek's disease with an attenuated Marek's disease virus

Avian Pathology, 1974
Approximately 2,000 day-old white leghorn chickens were distributed into 10 pens and half the pens vaccinated with the attenuated strain of HPRS-16. At 72 weeks of age, mortality from non-specific death and Marek's disease was 17.6% and 15.6% respectively, in vaccinated chickens compared with 14.2% and 51.7% in unvaccinated chickens.
C A, Jackson, P M, Biggs, R A, Bell, F M, Lancaster, B S, Milne   +4 more
openaire   +2 more sources

Cyclophosphamide-Induced Amelioration of Marek's Disease in Marek's Disease-Susceptible Chickens

American Journal of Veterinary Research, 1976
SUMMARY Bursa- and thymus-dependent functions were examined in Marek's disease (md)-susceptible normal chickens and in chickens treated with 5 and 16 mg of cyclophosphamide (cy) at the time of hatching. Chickens not exposed to Marek's disease virus (mdv) and treated with cy temporarily lost mitogenic response to concanavalin A but regained full ...
Y S, Lu, V, Kermani-Arab, T, Moll
openaire   +2 more sources

Genomics and Marek’s disease virus

Cytogenetic and Genome Research, 2007
Marek’s disease virus (MDV), a lymphotrophic alphaherpesvirus of chickens, causes a disease that is characterized by tumor formation, immunosuppression and neurological disorders. Recent developments in chicken genomics have been applied to studies of MDV and have advanced our understanding of both the virus and the disease it causes.
J, Burnside, R W, Morgan
openaire   +2 more sources

Herpesvirus in Marek's Disease Tumors

Science, 1969
Intranuclear and cytoplasmic virus particles of the herpes type were located in epithelial cells that line the kidney collecting tubules obtained from a chick with Marek's disease. The chick had contracted the disease by direct contact transmission. The virus was not observed in any of the invading tumor cells in the same kidney.
G, Schidlovsky, M, Ahmed, K E, Jensen
openaire   +2 more sources

Hematopoietic Destruction in Marek's Disease

Avian Diseases, 1970
Hematopoietic destructive lesions, characterized by necrosis and loss of architecture in the bursa of Fabricius and thymus, were observed consistently in second-generation specific-pathogen-free X Line 7 (SPF X L7-F2) cross chickens inoculated at 1 day with an acute form of Marek's disease (MD) agent.
R M, Jakowski, T N, Fredrickson, T W, Chomiak, R E, Luginbuhl   +3 more
openaire   +2 more sources